What impact do the proton pump inhibitors have on the efficacy of immune check point inhibitors in metastatic malignant melanoma?

被引：17
|
作者：
Afzal, Muhammad Zubair [1 ]
Shirai, Keisuke [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e21040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21040
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HHV6 and immune-mediated meningoencefalomyelitis after check point inhibitors treatment for melanoma
    Stetkarova, I.
    Svobodova, Z.
    Arenbergerova, M.
    Fialova, A.
    Malikova, H.
    Pasek, M.
    Arenberger, P.
    Ehler, E.
    Peisker, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 429 - 429
  • [42] CHECK-POINT INHIBITORS: WHAT ARE THEY USED FOR, ABOUT SIDE-EFFECTS AND PREDICTION OF EFFICACY
    Kapiteijn, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 26 - 26
  • [43] What Is the Real Impact of Concomitant Antibiotics or Proton Pump Inhibitors on Efficacy of Atezolizumab-Based Regimens in Patients With NSCLC?
    Mazzaschi, Giulia
    Buti, Sebastiano
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (10) : E89 - E90
  • [44] Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
    Poletajew, Slawomir
    Krajewski, Wojciech
    Kryst, Piotr
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2479 - 2482
  • [45] Impact of proton pump inhibitors and antibiotics on efficacy of nivolumab in patients with R/M HNSCC
    Wada, Akihisa
    Enokida, Tomohiro
    Okano, Susumu
    Sato, Masanobu
    Tanaka, Hideki
    Ueda, Yuri
    Fujisawa, Takao
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tahara, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S469 - S469
  • [46] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
  • [47] Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors
    Sue, Masahiko
    Takeuchi, Yasuto
    Hirata, Shoichiro
    Takaki, Akinobu
    Otsuka, Motoyuki
    CANCERS, 2024, 16 (10)
  • [48] Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors
    Ramel, Eloise
    Prey, Sorilla
    Dutriaux, Caroline
    Gerard, Emilie
    Pham-Ledard, Anne
    Beylot-Barry, Marie
    Kostine, Marie
    EUROPEAN JOURNAL OF CANCER, 2024, 197
  • [49] Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Dar, Sophia
    Merza, Nooraldin
    Rahim, Mehek
    Qatani, Ahmad
    Varughese, Tony
    Mohammad, Asna
    Masood, Fahad
    Reza, Fizza
    Wan, Schuchen
    Almas, Talal
    Ellahi, Aayat
    Ligresti, Rosario
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [50] Proton Pump Inhibitors: Do We Practice What We Preach? A Quality Improvement Intervention
    Shahnazarian, Vahe
    Kolli, Sree
    Nagaraj, Savitha
    Ramai, Daryl
    Reddy, Madhavi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1621 - S1622
12345